- Report
- November 2023
- 115 Pages
United States
From €2593EUR$2,625USD£2,157GBP
€3704EUR$3,750USD£3,082GBP
- Report
- November 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Report
- August 2023
- 295 Pages
Global
From €6568EUR$6,650USD£5,465GBP
€9383EUR$9,500USD£7,807GBP
- Report
- August 2023
- 147 Pages
Global
From €3284EUR$3,325USD£2,732GBP
€4691EUR$4,750USD£3,903GBP
- Report
- June 2023
- 115 Pages
United States
From €2593EUR$2,625USD£2,157GBP
€3704EUR$3,750USD£3,082GBP
- Report
- May 2023
- 450 Pages
Global
From €3457EUR$3,500USD£2,876GBP
€4938EUR$5,000USD£4,109GBP
- Report
- April 2023
- 180 Pages
Global
From €2074EUR$2,100USD£1,726GBP
€2963EUR$3,000USD£2,465GBP
- Report
- April 2023
- 164 Pages
Global
From €6568EUR$6,650USD£5,465GBP
€9383EUR$9,500USD£7,807GBP
- Report
- March 2023
- 30 Pages
Global
From €2247EUR$2,275USD£1,869GBP
€3210EUR$3,250USD£2,671GBP
- Report
- March 2023
- 30 Pages
Global
From €2247EUR$2,275USD£1,869GBP
€3210EUR$3,250USD£2,671GBP
- Report
- February 2023
- 134 Pages
Global
From €5185EUR$5,250USD£4,314GBP
€7407EUR$7,500USD£6,163GBP
- Report
- February 2023
- 67 Pages
Global
From €2731EUR$2,765USD£2,272GBP
€3901EUR$3,950USD£3,246GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more